COUP-TFII promotes colorectal carcinoma resistance to doxorubicin involving inhibition of epithelial-mesenchymal transition (vol 8, pg 3921, 2016)

Authors:

  • 1 January 2018
    • journal article
    • correction
Abstract
[This corrects the article on p. 3921 in vol. 8, PMID: 27725871.].